Haleon PLC Sponsored ADR (HLN)
NYSE:HLN
Want to see HLN full AI Analyst Report?
HLN Stock Chart & Stats
$9.52
$0.04(0.37%)
At close: 4:00 PM EST
$9.52
$0.04(0.37%)
Day’s Range― - ―
52-Week Range$8.65 - $11.28
Previous CloseN/A
Volume6.87M
Average Volume (3M)10.28M
Market Cap
$39.03B
Enterprise Value$36.80B
Total Cash (Recent Filing)$1.32B
Total Debt (Recent Filing)$8.59B
Price to Earnings (P/E)29.1
Beta0.11
Next Earnings
Jul 30, 2026EPS Estimate
0.13Next Dividend Ex-DateN/A
Dividend Yield1.74%
Share Statistics
EPS (TTM)0.37
Shares Outstanding4,415,081,000
10 Day Avg. Volume12,002,400
30 Day Avg. Volume10,284,714
Financial Highlights & Ratios
PEG Ratio1.67
Price to Book (P/B)2.05
Price to Sales (P/S)3.05
P/FCF Ratio17.06
Enterprise Value/Market Cap0.94
Enterprise Value/Revenue3.35
Enterprise Value/Gross Profit5.17
Enterprise Value/Ebitda13.02
Forecast
1Y Price Target
$11.00Price Target Upside15.55% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.56
Revenue Forecast (FY)$15.39B
Bulls Say, Bears Say
Bulls Say
Improving MarginsSustained gross and net margin expansion (220 bps gross improvement in 2025) reflects structural supply‑chain and productivity gains. Higher margins support durable cash generation, allow reinvestment in marketing/R&D, and improve resilience to top‑line volatility over coming quarters.
Strong Cash ConversionHigh FCF conversion and a large 2025 cash uplift indicate quality earnings and efficient working capital. Persistent cash generation gives the company options to deleverage, fund A&P/R&D, or support strategic initiatives without relying on external financing over the next 2–6 months.
Brand & E‑commerce StrengthLeading consumer brands (e.g., Sensodyne) and strong online capabilities (Amazon leadership, China e‑commerce share) create durable competitive advantages. Brand equity and channel mix support higher margin mix, faster digital growth, and sustained share gains in core categories over the medium term.
Bears Say
Soft Revenue & VolumesTop‑line softness and sub‑par volume trends constrain sustainable growth despite margin gains. If volumes remain low, revenue recovery will depend on pricing and mix rather than organic market expansion, limiting durable upside and slowing deleveraging or reinvestment efforts over the next several quarters.
Meaningful Debt LoadA structurally meaningful debt balance reduces financial flexibility and increases interest and refinancing risk if growth softens. Even with improving leverage metrics, the existing debt stock constrains capital allocation choices and heightens sensitivity to slower cash flow realization over the medium term.
U.S. & Category HeadwindsPersistent weakness in the U.S. and pressure in key categories (cold & flu, digestive, parts of pain) undermine the core market and can offset gains elsewhere. Channel destocking and retailer uncertainty make recovery timing uncertain, hampering sustainable top‑line improvement over 2–6 months.
Haleon PLC Sponsored ADR News
HLN FAQ
What was Haleon PLC Sponsored ADR’s price range in the past 12 months?
Haleon PLC Sponsored ADR lowest stock price was $8.65 and its highest was $11.28 in the past 12 months.
What is Haleon PLC Sponsored ADR’s market cap?
Haleon PLC Sponsored ADR’s market cap is $39.03B.
When is Haleon PLC Sponsored ADR’s upcoming earnings report date?
Haleon PLC Sponsored ADR’s upcoming earnings report date is Jul 30, 2026 which is in 39 days.
How were Haleon PLC Sponsored ADR’s earnings last quarter?
Haleon PLC Sponsored ADR released its earnings results on Feb 25, 2026. The company reported $0.129 earnings per share for the quarter, beating the consensus estimate of $0.124 by $0.005.
Is Haleon PLC Sponsored ADR overvalued?
According to Wall Street analysts Haleon PLC Sponsored ADR’s price is currently Undervalued.
Does Haleon PLC Sponsored ADR pay dividends?
Haleon PLC Sponsored ADR pays a Quarterly dividend of $0.133 which represents an annual dividend yield of 1.74%. See more information on Haleon PLC Sponsored ADR dividends here
What is Haleon PLC Sponsored ADR’s EPS estimate?
Haleon PLC Sponsored ADR’s EPS estimate is 0.13.
How many shares outstanding does Haleon PLC Sponsored ADR have?
Haleon PLC Sponsored ADR has 4,415,081,000 shares outstanding.
What happened to Haleon PLC Sponsored ADR’s price movement after its last earnings report?
Haleon PLC Sponsored ADR reported an EPS of $0.129 in its last earnings report, beating expectations of $0.124. Following the earnings report the stock price went down -5.785%.
Which hedge fund is a major shareholder of Haleon PLC Sponsored ADR?
Currently, no hedge funds are holding shares in HLN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Haleon PLC Sponsored ADR Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$11.00 (15.55% Upside)
$11.00 (15.55% Upside)
Blogger Sentiment
Neutral
HLN Sentiment 50%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 4.4M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 0.4%
Last 30 Days ▼ 0.4%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-12.67%
12-Months-Change
Fundamentals
Return on Equity
6.43%
Trailing 12-Months
Asset Growth
2.12%
Trailing 12-Months
Company Description
Haleon PLC Sponsored ADR
Haleon plc is a significant global entity in the consumer healthcare sector, engaging in the entire process from scientific research and development to the production and worldwide distribution of various wellness goods. The company's reach extends across North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific region. Its diverse product portfolio encompasses therapeutic solutions for oral care, pain management, respiratory well-being, and digestive health, alongside a comprehensive range of vitamins, minerals, and other dietary supplements. Noteworthy brands within its collection include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. Established in 2021, the company was initially known as DRVW 2022 plc before officially changing its name to Haleon plc in February 2022. It is headquartered in Brentford, United Kingdom.
HLN Company Deck
HLN Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call balances clear operational and strategic progress (notably strong margin/cost improvements, Oral Health outperformance, emerging markets growth, increased A&P/R&D investment, and a planned $175–$200M cost saving reorganization) against meaningful top-line and volume challenges (soft U.S. market, cold & flu season weakness, category-specific headwinds, and regional retailer/inventory issues). Management presented realistic 2026 guidance (3%–5%) while reiterating confidence in returning to the 4%–6% medium-term ambition as U.S. performance, distribution gains, and productivity benefits materialize.View all HLN earnings summariesHLN Stock 12 Month Forecast
Average Price Target
$11.00
▲(15.55% Upside)
Technical Analysis
Dr Reddy's Laboratories
―
Viatris
―
Perrigo Company
―
Teva Pharmaceutical
―
Takeda Pharmaceutical Company
―
Ownership Overview
―
Insiders
4.54% Mutual Funds
5.98% Other Institutional Investors
89.32% Public Companies and
Individual Investors